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We demonstrated previously that ET-1 and cAMP may syner-
gistically induce IL-6 release from adipocytes, mainly through
their strong stimulatory effect on IL-6 gene expression. In the
present study, we further examined the signaling pathways that
may be involved. A luciferase reporter driven by promoter
(−1310/+198) of mouse IL-6 gene was transfected into 3T3-L1
adipocytes to monitor IL-6 transcription in response to ET-1 and
8-bromo cAMP, and the effects of various inhibitory agents were
tested. Whereas the stimulatory effect of ET-1 alone was inhibited
by pertussis toxin (PT), GF109203X, U0126, N-acetylcysteine,
salicylate, dominant negative CREB (dn- CREB) and mithramycin
A, the stimulatory effect of 8-bromo cAMP was only inhibited by
dn-CREB. On the other hand, the synergistic effect of ET-1 and
cAMP was suppressed by GF109203X, U0126, salicylate, c-Jun-
speciﬁc antisense oligonucleotide (AS-cJun) and dn-CREB. PT had
a partial inhibitory effect, while NAC and mithramycin A had no
inﬂuence. Since NF-kB activation by ET-1 is mediated by a
PKC&epsilon/ROS cascade, the observation that the synergistic
effect of ET-1 and cAMP was inhibited by salicylate but not NAC
suggests salicylate inhibited some factor in addition to NF-kB. Indeed,
we found that another salicylate target p90 ribosomal S6 Kinase (RSK)
was involved. Taken together, the synergistic effect of ET-1 and cAMP
on IL-6 gene transcription seems to bemediated by pathways involving
PKC, MAPK, CREB, AP-1 and RSK.
doi:10.1016/j.lfs.2013.12.126
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Background: To develop a model to study of the mechanisms of
endothelin-1 (ET-1)-induced vascular injury, we generated an
inducible endothelial cell (EC)-restricted human ET-1 (EDN1) cDNA
overexpressing transgenic mouse. Methods and results: A transgene
was engineered that expresses chloramphenicol acetyltransferase (cat)
and EDN1 cDNA prior and after Cre-mediated excision, respectively,
under the control of cytomegalovirus immediate early enhancer/
chicken β-actin promoter (CAG). Co-transfection of Cre expression
vector and pCAG-cat-EDN1 caused 30-fold increase in ET-1 production.
Transgenic mice were generated and two of seven founder lines were
selected based on their cardiac cat expression level, which was twice
higher in line C-134 than C-170. Inducible EC-restricted EDN1 mice
were generated crossing CAG-cat-EDN1 mice with transgenic mice
expressing CreERT2 under control of EC-speciﬁc Tie2 promoter. To
investigate the extent of CreERT2 activation by tamoxifen and tissue
speciﬁcity, Tie2-CreERT2micewere crossedwith ROSAmT-mG/mT-mG
reporter mice expressing a membrane-targeted tandem dimer tomato
(mT) before Cre-mediated excision, and membrane-targeted enhanced
green ﬂuorescent protein (mG) after excision. Tie2-CreERT2/cat-EDN1
and Tie2-CreERT2/ROSAmT-mG/+ mice were treated subcutaneously
with 1 mg tamoxifen/day for 5 days and sacriﬁced 14–16 days later. mG
expression was detected in 22 ± 3% of mesenteric artery ECs of Tie2-
CreERT2/ROSAmT-mG/+ mice. Plasma ET-1 levels were similar in
vehicle-treated Tie2-CreERT2/cat-EDN1 (1.2 ± 0.1 pg/mL, n = 4) and
wild-type mice (1.1 ± 0.1 pg/mL, n = 2), demonstrating no leaky
expression. Tamoxifen induced 8-fold increase in plasma ET-1 levels
in Tie2-CreERT2/cat-EDN1 mice (9.1 ± 0.3 pg/mL, n = 4). Conclusion:
Tie2-CreERT2/cat-EDN1-inducible EC-restricted EDN1 overexpressing
mice allow the study of ET-1 vascular effects independently of
developmental effects.
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In human atherosclerosis, which is associated with elevated
plasma and coronary endothelin (ET)-1 levels, ETA receptor
antagonists improved coronary endothelial function. Mice overex-
pressing ET-1 speciﬁcally in the endothelium (eET-1) crossed with
apolipoprotein E knockout mice (Apoe−/−) exhibited exaggerated
high-fat diet (HFD)-induced atherosclerosis. Since endothelial
dysfunction often precedes atherosclerosis development, we inves-
tigated whether endothelium-speciﬁc ET-1 overexpression causes
endothelial dysfunction in Apoe−/− mice. Male 8-week old eET-1,
Apoe−/−, eET-1/Apoe−/− and wild-type mice were fed a regular
diet or HFD for 8 weeks. Endothelial function was assessed in
mesenteric arteries by pressurized myography. In HFD-fed mice,
acetylcholine-induced endothelium-dependent relaxation (EDR) was
reduced 67% in Apoe−/− and 41% in eET-1 compared to wild-type
(P b 0.05). Surprisingly, EDR was not impaired in eET-1/Apoe−/−
compared to wild-type. Endothelium-independent relaxation to
nitric oxide donor sodium nitroprusside and contractile responses
to norepinephrine were unaffected. Similar results were observed in
regular diet-fed mice. In the presence of inhibitors of either nitric
oxide synthase (NOS)-mediated relaxation, Nω-nitro-l-arginine methyl
ester, or endothelium-dependent hyperpolarization (EDH)-mediated
relaxation, apamin plus Tram34, EDR was blunted in wild-type
(P b 0.01), whereas NOS-mediated relaxation was reduced 22% (P b
0.05) and EDH-mediated relaxation unaffected in eET-1/Apoe−/−.
However, the concomitant inhibition of NOS- and EDH-mediated
relaxation reduced EDR 51% in eET-1/Apoe−/− (P b 0.05). These results
showan interdependence of NOS and EDHpathways in EDR inwild-type
mice. ET-1 overexpression induced development of compensatory
mechanisms in pre-atherosclerotic arteries of Apoe−/− mice, which
permits either NOS or EDH pathway to mediate EDR independently.
Investigation of mechanisms involved in EDR remodeling in eET-1/
Apoe−/− mice will allow a better understanding of the ET-1 role in
atherosclerosis.
doi:10.1016/j.lfs.2013.12.128
Abstractse36
